在遗传神经肌肉疾病中,通过人工智能赋予临床医生权力
Andi Nuredini1, Marco Savarese2, Filippo Maria Santorelli3
1Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
概括
人工智能 (AI) 为诊断和管理复杂的神经肌肉疾病 (NMDs) 提供了革命性的潜力. CoMPaSS-NMD项目培训临床医生利用人工智能来改善患者分层和护理.
科学领域:
- * 医学信息学和人工智能
- *神经学和遗传学 *神经学和遗传学
背景情况:
- *神经肌肉疾病 (NMDs) 具有显著的临床和遗传复杂性,需要先进的诊断和管理策略.
- *人工智能 (AI) 在医疗保健中的整合显示出对NMD诊断和治疗进行革命的希望.
- * 熟练的劳动力对于在NMD护理中有效利用AI至关重要.
研究的目的:
- * 引入CoMPaSS-NMD项目的AI驱动的NMD患者分层的跨学科框架.
- *强调统一方法和共同语言在推进NMD研究中的重要性.
- *强调年轻研究员培训 (YIT) 计划在准备未来NMD专家方面的作用.
主要方法:
- * 开发人工智能驱动的患者分层策略,使用综合的临床,组织病理学,MRI和遗传数据.
- * 建立一个跨学科的框架,以促进合作和知识共享.
- * 实施年轻研究员培训 (YIT) 倡议,用于早期职业生涯的研究人员教育.
主要成果:
- * CoMPaSS-NMD项目开创了一种通过AI进行NMD患者分层的新方法.
- *该倡议促进跨学科合作,弥合不同科学领域之间的差距.
- * YIT 计划有效地培养了早期职业研究人员对 NMDs 的 AI 应用.
结论:
- *人工智能整合,在跨学科合作和专业培训的支持下,是推动NMD诊断和管理的关键.
- * CoMPaSS-NMD项目及其YIT倡议对于开发下一代人工智能驱动的NMD护理专家至关重要.
- *通过这些创新方法,可以显著改善NMD的个性化治疗和早期诊断.
更多相关视频
10:28Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
Published on: April 3, 2021
6.5K
06:51Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
7.8K
相关概念视频
Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
Myasthenia Gravis: Overview and Treatment
2.0K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.0K
